We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DARE market cap is 27.79M. The company's latest EPS is USD -0.3060 and P/E is -0.92.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1M |
| Operating Income | -7.14M | -16.23M | -8.38M | -8.99M | -8.4M |
| Net Income | -7.02M | -15.94M | -8.04M | -8.76M | -8.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 10M | 2.81M |
| Operating Income | -14.34M | -27.4M | -39.07M | -31.39M | -30.94M |
| Net Income | -15.05M | -27.4M | -38.7M | -30.95M | -30.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 50.38M | 43.83M | 30.37M | 23.21M | 25.05M |
| Total Liabilities | 24.03M | 32.71M | 25.4M | 25.93M | 27.34M |
| Total Equity | 26.34M | 11.11M | 4.97M | -2.72M | -2.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.44M | 7.55M | 55.81M | 43.83M | 21.28M |
| Total Liabilities | 7M | 8.7M | 17.05M | 32.71M | 26.33M |
| Total Equity | 441k | -1.15M | 38.75M | 11.11M | -5.05M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.19M | -18.09M | -16.12M | -22.7M | -30.68M |
| Investing | -60k | -63k | N/A | N/A | -22k |
| Financing | 1.34M | 1.34M | 1.3M | 1.75M | 10.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.32M | -25.24M | -28.76M | -18.09M | -38.86M |
| Investing | 6.14M | -18k | -15k | -63k | -629k |
| Financing | 5.15M | 25.13M | 75.85M | 1.34M | 15.64M |
| Market Cap | 27.79M |
| Price to Earnings Ratio | -0.92 |
| Price to Sales Ratio | 9.82 |
| Price to Cash Ratio | 2.63 |
| Price to Book Ratio | -5.47 |
| Dividend Yield | - |
| Shares Outstanding | 98.56M |
| Average Volume (1 week) | 1.12M |
| Average Volume (1 Month) | 471.73k |
| 52 Week Change | -72.62% |
| 52 Week High | 1.10 |
| 52 Week Low | 0.27 |
| Spread (Intraday) | 0 (0.21%) |
| Company Name | Dare Bioscience Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.darebioscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
